Drug Trial Radar · NCT00434083
To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches
Last checked: Nov 19, 2026Latest source record: Feb 12, 2007 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,200
Actual
Start
Jul 2004
Primary completion
Not stated
Study completion Jan 2005
Sponsor
- Lead sponsor
- POZENIndustry
- Sponsor type
- Industry
- First posted
- Feb 12, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
* to demonstrate the superiority of Trexima (combination of sumatriptan as the succinate 85 mg and naproxen sodium 500 mg) versus placebo in the acute treatment of migraine * to demonstrate the superiority of Trexima versus the individual components (sumatriptan as the succinate 85 mg and naproxen sodium 500 mg), and * to evaluate the safety of the Trexima.
Conditions
- Migraine Headaches
Interventions
sumatriptanDrug
naproxen sodiumDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Trexima will be evaluated for efficacy as an acute treatment for migraine based on its superiority over placebo at 2 hours for: a) pain relief (no or mild pain), b) incidence of photophobia, c) incidence of phonophobia and d) incidence of nausea.
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Pozen, Inc.
Chapel Hill, North Carolina
Nashville Neuroscience Group, PC
Nashville, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.